Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion cash
Cash and short-term investments held at the end of each period.
Aclarion's cash was $16.29M at Jun 30, 2026. For fiscal 2025 it was $12.02M, up 2491.5% from the year before. The highest annual figure on record is $12.02M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.02M | +2491.5% |
| FY2024 | Dec 31, 2024 | $463.66K | -55.0% |
| FY2023 | Dec 31, 2023 | $1.03M | -30.5% |
| FY2022 | Dec 31, 2022 | $1.48M | +227.7% |
| FY2021 | Dec 31, 2021 | $452.53K | +2920.1% |
| FY2020 | Dec 31, 2020 | $14.98K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.29M | +26.7% |
| Q1 FY2026 | Mar 31, 2026 | $19.00M | +28.8% |
| Q4 FY2025 | Dec 31, 2025 | $12.02M | +2491.5% |
| Q3 FY2025 | Sep 30, 2025 | $11.34M | +757.8% |
| Q2 FY2025 | Jun 30, 2025 | $12.85M | +986.6% |
| Q1 FY2025 | Mar 31, 2025 | $14.76M | +588.9% |
| Q4 FY2024 | Dec 31, 2024 | $463.66K | -55.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.32M | +671.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.18M | +92.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.14M | +367.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.03M | -30.5% |
| Q3 FY2023 | Sep 30, 2023 | $171.45K | -93.6% |
| Q2 FY2023 | Jun 30, 2023 | $614.52K | -83.8% |
| Q1 FY2023 | Mar 31, 2023 | $457.98K | +1.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.48M | +13.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.67M | +27.5% |
| Q2 FY2022 | Jun 30, 2022 | $3.80M | +5852.2% |
| Q4 FY2021 | Dec 31, 2021 | $452.53K | +2920.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.30M | – |
| Q2 FY2021 | Jun 30, 2021 | $2.09M | – |
| Q1 FY2021 | Mar 31, 2021 | $63.89K | – |
| Q4 FY2020 | Dec 31, 2020 | $14.98K | – |